Companies /Healthcare

Enveric Biosciences Inc

NASDAQ: ENVB Biotechnology
$1.45
▼ $0.02 (−1.36%) today
Markets closed · 5:04am ET

Fundamentals

Market Cap
$6.6M
Revenue (TTM)
$35.4M
EPS (TTM)
$-11.94
52-Week Range
$1 – $13
Street Target
$10.00

About Enveric Biosciences

Enveric Biosciences, Inc., a pharmaceutical company, is dedicated to developing various cannabinoid drugs for the treatment of cancer. The company is headquartered in Naples, Florida.

ENVB Coverage